NZ210634A - Purification of recombinant human interleukin - 2; pharmaceutical compositions - Google Patents

Purification of recombinant human interleukin - 2; pharmaceutical compositions

Info

Publication number
NZ210634A
NZ210634A NZ210634A NZ21063484A NZ210634A NZ 210634 A NZ210634 A NZ 210634A NZ 210634 A NZ210634 A NZ 210634A NZ 21063484 A NZ21063484 A NZ 21063484A NZ 210634 A NZ210634 A NZ 210634A
Authority
NZ
New Zealand
Prior art keywords
purification
recombinant human
human interleukin
pharmaceutical compositions
lysis
Prior art date
Application number
NZ210634A
Inventor
Kung Hsiang-Fu
Yamazaki Shigeko
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ210634A publication Critical patent/NZ210634A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Homogeneous recombinant human interleukin-2 is prepared by extraction of IL-2 from the cell membrane components of transformed microorganisms after lysis and purification of the extract by chromatography. <IMAGE>
NZ210634A 1983-12-23 1984-12-19 Purification of recombinant human interleukin - 2; pharmaceutical compositions NZ210634A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56498683A 1983-12-23 1983-12-23

Publications (1)

Publication Number Publication Date
NZ210634A true NZ210634A (en) 1989-05-29

Family

ID=24256731

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ210634A NZ210634A (en) 1983-12-23 1984-12-19 Purification of recombinant human interleukin - 2; pharmaceutical compositions

Country Status (12)

Country Link
EP (1) EP0147819B1 (en)
JP (2) JPH0728753B2 (en)
AT (1) ATE76905T1 (en)
AU (1) AU580276B2 (en)
CA (1) CA1340853C (en)
DE (1) DE3485759D1 (en)
DK (1) DK174501B1 (en)
IE (1) IE57914B1 (en)
IL (1) IL73882A (en)
NZ (1) NZ210634A (en)
PH (1) PH19584A (en)
ZA (1) ZA849910B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
JPS60115528A (en) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd Human interleukin-2 protein, its production and pharmacological composition containing the same
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
IL76360A0 (en) * 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
WO1986002068A1 (en) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Mutual separation of proteins
WO1986007093A1 (en) * 1985-05-29 1986-12-04 The Green Cross Corporation Process for preparing heterogenic protein
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
WO1987000553A1 (en) * 1985-07-16 1987-01-29 The Green Cross Corporation Process for preparing hetero-protein
US5831022A (en) * 1986-02-18 1998-11-03 Hoffmann-La Roche Inc. Purification of recombinant human IL-1α
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US5162503A (en) * 1987-05-19 1992-11-10 Hoffmann-La Roche, Inc. Purification of interleukin-2 by receptor-affinity chromatography
EP0337243A1 (en) * 1988-04-14 1989-10-18 F. Hoffmann-La Roche Ag Process for purifying recombinant human interleukin-2
ZA898139B (en) * 1988-11-17 1990-08-29 Hoffmann La Roche Recombinant interleukin-2 hybrid proteins
IT1262981B (en) * 1992-09-09 1996-07-23 Tecnogen Scpa PROCEDURE FOR PURIFYING THE BIG ENDOTELINE PROTEIN
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
JP2006141263A (en) * 2004-11-18 2006-06-08 Kyoto Univ Method for producing (r)-hydroxynitril lyase
RU2565553C2 (en) * 2013-04-09 2015-10-20 Общество с ограниченной ответственностью "Стратегия" Method of obtaining interleukin-2 preparation, interleukin-2 preparation and pharmaceutical immunomodulating preparation
CA2954476C (en) * 2014-07-10 2023-09-19 Novartis Ag Immune-stimulating monoclonal antibodies against human interleukin-2
MA43859A (en) 2016-01-11 2018-11-21 Novartis Ag HUMANIZED MONOCLONAL ANTIBODIES IMMUNOSTIMULANTS DIRECTED AGAINST HUMAN INTERLEUKIN -2, AND THEIR FUSION PROTEINS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58159420A (en) * 1982-03-18 1983-09-21 Ajinomoto Co Inc Purification method of interleukin 2
EP0091539B2 (en) * 1982-03-31 1996-11-27 Ajinomoto Co., Inc. Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
DE3378128D1 (en) * 1982-04-20 1988-11-03 Sloan Kettering Inst Cancer Purification of interleukin 2
JPS58198293A (en) * 1982-05-12 1983-11-18 Shionogi & Co Ltd Production of immunoregulator such as interleukin
JPS59144719A (en) * 1983-02-03 1984-08-18 Japan Found Cancer Gene coding interleukin-2 polypeptide, recombined dna substance containing gene, and preparation of interleukin-2 using live cell strain containing dna substance and cell
ZA842025B (en) * 1983-03-21 1984-11-28 Hoffmann La Roche Interleuken-2
JPS60115528A (en) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd Human interleukin-2 protein, its production and pharmacological composition containing the same
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
DE3419995A1 (en) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt GENE TECHNOLOGICAL METHOD FOR PRODUCING HUMAN INTERLEUKIN-2 AND MEANS FOR CARRYING OUT THIS METHOD

Also Published As

Publication number Publication date
ATE76905T1 (en) 1992-06-15
JP2864996B2 (en) 1999-03-08
DK174501B1 (en) 2003-04-28
JPH0728753B2 (en) 1995-04-05
EP0147819A3 (en) 1987-09-23
JPH07233082A (en) 1995-09-05
EP0147819A2 (en) 1985-07-10
IE57914B1 (en) 1993-05-19
DE3485759D1 (en) 1992-07-09
DK612484A (en) 1985-06-24
ZA849910B (en) 1985-09-25
AU3699584A (en) 1985-07-04
JPS60172295A (en) 1985-09-05
DK612484D0 (en) 1984-12-19
CA1340853C (en) 1999-12-21
PH19584A (en) 1986-05-26
IL73882A0 (en) 1985-03-31
IE843320L (en) 1985-06-23
EP0147819B1 (en) 1992-06-03
AU580276B2 (en) 1989-01-12
IL73882A (en) 1989-05-15

Similar Documents

Publication Publication Date Title
NZ210634A (en) Purification of recombinant human interleukin - 2; pharmaceutical compositions
IT1164626B (en) PROCEDURE FOR THE RECOVERY OF HUMAN IFN-B FROM TRANSFORMED PRODUCER MICROORGANISMS
PH21012A (en) Process for recovering microbially produced interleukin-2 and purified recombinant interleukin 2 compositions
IL69731A (en) Homogeneous human interleukin 2,its preparation and pharmaceutical compositions containing it
DE3370482D1 (en) Substituted 8-phenylxanthines
IL76454A0 (en) Diarylacetylenes,their preparation and pharmaceutical compositions containing them
AU579359B2 (en) Stable composition of interleukin-2
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
AU581010B2 (en) Novel pharmaceutical use of (NVA)``-cyclosporine
EP0149551A3 (en) Gamma interferon-interleukin-2 synergistic compositions and processes therefor
AU4482985A (en) Pyrro-1-yl-phenyl-dihydropyridazones
AU4473185A (en) Phenyl-substituted naphthyridines and their use as anti-ulcer drugs
PT82554A (en) Process for the preparation of (2,4,5-cis)dioxane and compositions therewith
IE871358L (en) Interferon for carcinoma
ES8706138A1 (en) Benzoyl ureas.
DE3665861D1 (en) Basically substituted phenylacetaldehydes, their preparation and therapeutic compositions containing them
IE55801B1 (en) Novel vitamin d analogs
DK92183A (en) 11BETA-CHLOR-DELTA15-STEROIDS, PROCEDURES FOR THE PRODUCTION OF IT, AND PHARMACEUTICAL PREPARATIONS WITH CONTENTS
ES8404187A1 (en) Carcinoembryonic antigen, process for its isolation and use thereof.
IT1209617B (en) PROCEDURE FOR THE PREPARATION OF ALCHYLARYLETERS.
AU551840B2 (en) Pharmaceutical compositions containing an extract of mandassi
JO1493B1 (en) Pharmaceutical compositions for the treatment of high blood pressure
Ohkawa Cell electrophoresis using agarose gel
JO1209B1 (en) Pharmaceutical formulations comprising human insulin and human proinsulin.